+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

From
Narcolepsy Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Narcolepsy Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 191 Pages
  • Global
From
Divalproex Sodium Market - Global Forecast 2025-2032 - Product Thumbnail Image

Divalproex Sodium Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
From
Neurodegenerative Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurodegenerative Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 184 Pages
  • Global
From
Dystonia Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Dystonia Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Citicoline Market - Global Forecast 2025-2032 - Product Thumbnail Image

Citicoline Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
From
From
Neuropathic Pain Drug Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neuropathic Pain Drug Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
Narcolepsy Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Narcolepsy Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 193 Pages
  • Global
From
From
Anti-vertigo Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-vertigo Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Ropinirole HCL Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ropinirole HCL Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
From
Quantum-Dot Neuroscience Probe Global Market Report 2025 - Product Thumbnail Image

Quantum-Dot Neuroscience Probe Global Market Report 2025

  • Report
  • November 2025
  • 250 Pages
  • Global
From
5-HT2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
5-HT1D Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1D Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Parkinson's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Parkinson's Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Myotonic Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Myotonic Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more